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Abstract
Purpose/Objectives—To examine patterns and organizational correlates of personal protective 
equipment (PPE) use and hazardous drug spills.
Design—Cross-sectional mailed survey.
Setting—Ambulatory practices in California, Georgia, and Michigan.
Sample—252 Oncology Nursing Society members who administer hazardous drugs.
Methods—Bivariate and multivariable regression analyses.
Main Research Variables—Outcomes were PPE use and hazardous drug spills. Covariates 
included nursing workloads, nurses’ practice environments, and barriers to PPE use.
Findings—26% reported a recent drug spill. 90% wore only one pair of chemotherapy-tested 
gloves. Increased PPE use was significantly associated with nurse participation in practice affairs 
(β = 0.25, 95% CI 0.10 to 0.41), non-private ownership (β= 0.37, 95% CI 0.10 to 0.64), increased 
nursing workloads (β = 0.03, 95% CI 0.01 to 0.04), and fewer barriers to PPE use (β = 0.65, 95% 
CI 0.36 to 0.93). Spills were significantly associated with less favorable manager leadership and 
support (OR 0.68, 95% CI 0.47 to 0.98), and higher workloads (OR 1.03, 95% CI 1.01 to 1.06).
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Conclusions—Drug spills occur often in ambulatory settings. PPE use remains low and barriers 
to use persist. Higher workloads are associated with both lower PPE use and more spills.
Implications—Managers should monitor and correct aberrant workloads and assure PPE is 
available and staff are trained.
Knowledge Translation—1) Workloads are an important factor to consider in reducing 
hazardous drug exposures. 2) Nurses report substantial barriers to exposure prevention, including 
absence of equipment and lack of training. 3) Educational interventions are needed to improve use 
of PPE and reduction in hazardous drug exposures
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An estimated 8 million United States health care workers are potentially exposed to 
hazardous drugs annually (Connor & McDiarmid, 2006; Randolph, 2012). Oncology nurses 
prepare and administer substantial volumes of antineoplastic drugs, as roughly 18 million 
doses are administered to adults in the United States annually (Cherry, Woodwell, & 
Rechtsteiner, 2007). Urinary and blood metabolites have been detected in nurses who handle 
these drugs (Connor et al., 2010). Adverse health effects from exposures include acute 
effects (skin rashes, eye irritation, nausea), as well as long-term adverse reproductive issues 
(infertility, spontaneous abortions, congenital anomalies), and possibly cancers (National 
Institute for Occupational Safety and Health (NIOSH), 2004; Occupational Safety and 
Health Administration, 1999).
Despite over 30 years of efforts to improve personal protective equipment (PPE) use and 
safe-handling guidelines, recent studies have documented work surface contamination and 
dermal, eye, and inhalation exposure among oncology nurses who report hazardous drug 
spills (Friese, Himes-Ferris, Frasier, McCullagh, & Griggs, 2012; Kopp, Schierl, & Nowak, 
2013). The National Institute for Occupational Safety and Health (NIOSH) 2004 Alert 
reported workplace hazardous drug exposure as a persistent problem among health care 
workers (National Institute for Occupational Safety and Health (NIOSH), 2004). The use of 
chemotherapy-tested gloves, single-use disposable gowns, respirators/masks, eye protection, 
and closed-system transfer devices are recommended to protect against unintentional 
exposures (Valanis, Vollmer, Labuhn, Glass, & Corelle, 1992). However, studies that 
evaluated nurses’ safety handling performances have highlighted frequent barriers to PPE 
use. Despite increased availability of recommended PPE in workplaces, these devices are not 
always accepted, appropriate, or accessible to nurses (Boiano, Steege, & Sweeney, 2014b; 
Martin & Larson, 2003; Polovich & Clark, 2012a).
Both the Oncology Nursing Society and the American Society of Clinical Oncology 
recommend consistent PPE use to reduce drug spills and subsequent exposure (Jacobson et 
al., 2009). Yet it is less clear what organizational factors may influence PPE use and drug 
exposure. A 2012 survey of nurses found that lower workloads, nurse participation in 
decision making, adequate staffing, and two-nurse order verification were associated with 
lower odds of skin or eye exposure to hazardous drugs (Friese et al., 2012). Additional 
He et al. Page 2













studies have shown that fewer reported barriers to protective equipment use and more 
frequent performance of safety-promoting behaviors were associated with improved 
hazardous drug safe-handling precautions (Friese et al., 2014; Polovich & Clark, 2012a). Yet 
few studies have examined organizational factors and barriers across diverse ambulatory 
settings. A better understanding of mechanisms by which broader organizational structures 
and processes protect oncology nurses from potential hazardous drug exposure is necessary 
to inform interventions.
Nurse reports of hazardous drug spills provide insights into the context of understanding 
high-risk adverse events. We used a cross-sectional multi-state survey of oncology nurses to 
identify associations between organizational factors and reported barriers and two key 
outcomes: PPE use and self-reported drug spills. The results will inform policymakers, 
clinical administrators, and clinicians on how to improve PPE use and reduce potential 
exposures and potential harm to healthcare workers,
Methods
In 2014, members of the Oncology Nursing Society who resided in Michigan, Georgia, or 
California (n=654) and held part- or full-time employment status in ambulatory oncology 
settings were invited to respond to a mailed survey. Using Dillman’s total design method to 
maximize response rates (Dillman, Smyth, & Christian, 2008), we personalized cover letters, 
provided $40 up-front cash incentives, and sent up to three monthly reminders to non-
responders. Participants completed a mailed questionnaire from February through 
September 2014.
The questionnaire included items relating to the two outcomes of PPE use and hazardous 
drug spills, key covariates of organizational structure, perceived barriers to PPE use, and 
personal and practice factors. Measures were selected due to their congruence with 
Donabedian’s Quality of Care Model (Donabedian, 2005) and extant frameworks that 
examine PPE use by workers (McCullagh, Ronis, & Lusk, 2010).
The study examined two primary outcomes: self-reported PPE use and hazardous drug spills 
within the last six months. The Revised Hazardous Drug Handling Questionnaire measures 
frequency of using PPE when preparing or administering hazardous drugs (Martin & Larson, 
2003; Polovich & Clark, 2012b). This scale measures use of chemotherapy-tested gloves, 
double gloving technique, single-use disposable gowns, eye protection, respirators/masks, 
and closed-system transfer devices on a 6-point Likert Scale (0 = never, 5 = always). The 
PPE outcome was derived from a mean score of the six items. The second outcome - 
reported hazardous drug spills – was treated as a binary outcome; nurses were asked if they 
had experienced a spill, drop or leak of hazardous drugs greater than 5 mLs within the last 
six months (yes or no).
The Safety Organizing Scale measures collective behaviors performed by employees in 
high-reliability organizations (e.g., nuclear power plants) to mitigate high-stakes operational 
failures (Vogus & Sutcliffe, 2007). The 9-item scale measures the present safety 
performance and modifiable actions of clinicians. Items are scored on a 7-point Likert scale 
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ranging from not at all (1) to a very great extent (7) that safety behaviors are performed at 
the workplace. This scale has demonstrated high internal reliability and validity (Vogus & 
Sutcliffe, 2007; Wilson, 2013).
Nursing practice environments are features of workplaces that enable nurses to deliver high-
quality care (Lake & Friese, 2006). Environments were measured using the Practice 
Environment Scale of the Nursing Work Index (PES-NWI), as revised for ambulatory 
oncology settings. The revised PES-NWI items reflect the presence of six key work features: 
collegial nurse-physician relations; participation in practice affairs; managers’ ability, 
leadership and support; staffing and resource adequacy; supportive relations with medical 
assistants, and; foundations for quality care. A total of 23 items are scored on a 5-point 
Likert scale, ranging from strongly disagree (1) to strongly agree (5). Higher scores reflect 
more positive environments. Each sub-scale was derived from item means. Sub-scales have 
documented validity and reliability in prior studies (Cronbach alphas for internal consistency 
ranged from 0.80–0.90) (Shang, Friese, Wu, & Aiken, 2013).
Nurses’ reported barriers to wearing PPE were measured from 13 items in Geer’s Dermal 
Exposure Survey (Geer, Curbow, Anna, Lees, & Buckley, 2006). Nurses scored items on a 5-
point Likert scale from strongly disagree (1) to strongly agree (5); the mean across all 13 
items was used in analyses. In addition, nurses reported their average workloads (average 
number of patients cared for during the last shift), oncology practice ownership (privately 
owned vs. other), and demographics (years of nursing experiences, oncology certification, 
education level).
Statistical analyses were performed with SAS 9.4. Relationships between the two outcome 
variables and dependent variables were explored with bivariate analyses, including 
independent-sample t-tests and chi-square tests. Based on the distribution of the outcomes, 
linear regression models were used to estimate PPE use, with generalized estimating 
equations specified to account for clustering of nurses within practices. To examine factors 
associated with hazardous drug spills, multivariable logistic regression models were 
estimated with generalized estimating equations. To achieve parsimonious models, backward 
selection procedures removed variables that did not reach significance at p < .30. Final 
models retained main effect covariates that reached significance at p <.05. Interaction terms 
between barriers to PPE and organizational factors were also tested (Knol & VanderWeele, 
2012).
Results
In total, 467 nurses completed surveys (70.5% response). Participant information is shown in 
Table 1. Most participants were female (97%), 43 years or older (79%) with at least 6 years 
of oncology experience (75%), and worked in outpatient oncology settings (96%). Nurses 
worked in 132 oncology facilities in California (63% of total), Michigan (21%) and Georgia 
(16%), with a range of 1 to 12 nurses employed per facility. Slightly more nurses worked in 
public, non-profit, or government-owned practices (57%) than privately-owned practices 
(43%). When asked the average direct care workload during nurses’ last work shift, 72% of 
respondents reported providing care to five to nine patients. The final analytical sample 
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(n=252) excluded 23 respondents who did not meet study criteria, and 192 nurses whose 
routine work did not include preparing or administering hazardous drugs. We did not 
observe significant differences among study variables between the analytic sample and 
excluded participants.
The sample mean (SD) for the PPE use score was 2.4(1.0) out of a maximum possible score 
of 5. In particular, 224 respondents (90%) wore only one pair of chemotherapy-tested gloves 
at least 75% of the time during routine administration/preparation activities. However, 22% 
to 44% of the nurses reported “never” using other recommended PPE or techniques such as 
gowns, eye protection, double gloving and closed system transfer devices while handling 
hazardous drugs.
Table 2 shows results from the multivariable linear model for the outcome of PPE use and 
were adjusted for non-profit ownership and nursing workloads. Backward selection 
procedures reduced the number of variables included to five. Increased nurse participation in 
practice affairs, fewer barriers to PPE use, non-profit ownership, and higher workloads were 
significantly associated with higher scores on the PPE use scale. Collegial nurse-physician 
relationships were significantly associated with lower scores on PPE use.
Among nurses who routinely prepared or administered hazardous drugs, 51(26%) reported a 
spill, drop or leak of hazardous drugs of 5 mLs or more within the last six months. 
Contextual data regarding the spills are provided below (no table). Five exposed individuals 
reported skin contact or eye contact and four participants reported acute health problems 
including coughing, nose-burning sensation, and headache. When asked if nurses were 
concerned about the spill, 25(50%) of the respondents expressed they were somewhat or 
strongly concerned about the spill. During the spill response, nurses reported wearing the 
following PPE: 41(80%) used gowns, 29(57%) used chemotherapy-tested gloves, 20(39%) 
wore double gloves, 28(55%) wore respirators/masks, and 23(45%) wore eye protection. 
Spills occurred during the following activities: 8(15%) patient-related issue, 9(18%) 
prepping/spiking intravenous bags, 25(50%) starting/during infusion, 8(15%) drug storage/
disposal, 2(<1%) equipment malfunction. Among 17 nurses who used a closed system 
transfer device during a recent spill, 10 (62%) of them reported a device malfunction.
Table 3 compares organizational factors for those who did and did not report spills. Nurses 
who reported a hazardous drug spill within the last six months had significantly lower Safety 
Organizing Scale scores, lower scores on two PES-NWI subscales (nurse participation in 
practice affairs and manager ability, leadership & support), and increased barriers to PPE 
use.
After backward selection procedures, three variables were retained in the logistic regression 
model that estimated the odds of a hazardous drug spill report (Table 4). After adjusting for 
barriers to PPE use, nurses who reported favorable nurse manager ability, leadership, and 
support were significantly less likely to report a hazardous drug spill (OR 0.68, 95% CI: 
0.47, 0.98, p = .04). As nursing workloads increase by one patient, the odds of a hazardous 
drug spill increase by 3 percent (OR 1.03, 95% CI: 1.01, 1.06, p = .01).
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For over 30 years, recommendations for hazardous drug safe-handling practices have 
remained relatively constant, yet suboptimal PPE use and hazardous drug spills among 
oncology nurses are persistent problems. PPE use has increased overall, as reflected in prior 
work that documents increased glove use from a historic low of 49% to 90% in the current 
study (Boiano et al., 2014b; National Institute for Occupational Safety and Health (NIOSH), 
2004). However, not all recommended types of PPE are accepted, available or accessible in 
oncology workplaces. Other recommended types of PPE and procedures, including single-
use disposable gowns, double gloving practices, eye protection, respirators, and closed 
system transfer devices, are used less frequently outside of hospital inpatient settings. In our 
study, 22% to 44% of nurses reported “never” using the latter items. This finding 
underscores persistent organizational challenges to improve PPE access and adoption.
Consistent with prior studies, survey findings suggest that improved nursing participation in 
decision making in the practice and fewer barriers can enhance PPE use (Boiano, Steege, & 
Sweeney, 2014a; Martin & Larson, 2003; Polovich & Clark, 2012b). We observe a 
counterintuitive relationship between collegial nurse-physician relationships and lower PPE 
use. It is possible that practices with positive nurse-physician relationships are less formal 
work environments and may lack standardized processes for routine work. There may be 
interaction effects among practice ownership, practice size, and nurse physician 
relationships that could not be tested in the current study. Efforts to improve PPE use in the 
workplace can occur through engaging nurses in selecting appropriate PPE for purchase, 
ensuring open communication with facility administrators, and providing opportunities for 
nurses to participate in decision making. After adjusting for other factors, perceived barriers 
to PPE use remains the most significant factor associated with PPE use (Sadoh, Fawole, 
Sadoh, Oladimeji, & Sotiloye, 2006).
Our study found higher PPE use among nurses employed by university, public, and 
government practices. As practice ownership cannot likely be modified, the study findings 
underscore the need to improve individual adherence through modifiable administrative 
controls (e.g., commitments to safety culture, improved nurse practice environments, 
thoughtful attention to nursing workloads, and deployment of engineering controls).
Our findings suggest lower nursing workloads and more favorable manager support are 
correlated with fewer reported drug spills. Hazardous drug spills occur relatively frequently, 
which speaks to the need for increased management attention. Study results document spills 
relating to infusion, patient handling, medical device malfunction, and storage/disposal. 
Engineering controls did not reliably operate as designed.
There are several limitations to the current study. The internal reliability of our dependent 
variable – the PPE use scale – was lower in our sample (0.61) than reported previously (Geer 
et al., 2006). The distribution of various types of PPE (included on the PPE use scale) had a 
bimodal pattern; many respondents either reported using PPE very frequently or never. Other 
limitations included a varying number of respondents per practice and missing data. The 
cluster size varied from 1 to 12 nurses per practice, and roughly one-third of practices had 
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only one nurse informant. These limitations are somewhat offset by a large sample size, 
excellent response rate, and geographic diversity.
Implications for Nursing Practice and Research
Three decades of study have failed to solve the problem of inadequate attention to hazardous 
drug handling. Our study identifies the need for intervention at both the personal and 
organizational level. Employers need to ensure workers are adequately protected through 
increased adherence to engineering, administrative, and PPE control measures. Health care 
facilities managers may benefit from guidance in how to reduce the risk of hazardous drug 
exposure among employees, such as by facilitating clinician input on decisions and smooth 
workloads, and eliminating structural barriers to PPE use. Indeed, the barriers identified in 
this study were used to design the intervention to improve PPE use examined in a multi-site 
randomized clinical trial (Friese et al., 2015). Finally, additional longitudinal studies are 
needed to test the efficacy and effectiveness of interventions that are designed at both the 
individual and organizational level.
Conclusions
In this three-state sample of oncology nurses who administer hazardous drugs, more 
frequent use of PPE was associated with higher nurse participation in practice affairs and 
non-profit ownership. Inverse associations between PPE use and higher physician-nurse 
collaboration and patient workloads per shift. Self-reported hazardous drug spills occurred 
less often with increased performance of safety behaviors, more favorable perceptions of 
management, adequate staffing and resources, and lower barriers to using PPE. The high rate 
of spills and associated risk of exposure to hazardous drugs suggests that there is a need for 
employers to increase their efforts to protect workers through use of more effective 
engineering, administrative, and PPE controls.
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Table 1
Participant Characteristics
Analytic Sample (N=252) Survey Sample (N=437)
Mean (±SD) Mean (±SD)
Age 51 (± 10.5) 50 (± 10.5)
Years in Oncology 13.1 (± 9.5) 14 (± 9.5)
Nurse Workload 8.6 (± 7.6) 9.9 (± 18.2)
n Percent n Percent
Practice Ownership
-Private 103 42 153 36
-Non-Private 142 58 275 64
States
-California 157 63 250 57
-Georgia 43 17 79 18
-Michigan 52 20 108 25
Education
-Diploma or Associate degree 128 51 182 42
-Bachelor’s degree or higher 121 49 248 58
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Table 2
Organizational Factors and Personal Protective Equipment Use*
Parameter Estimate (95 % CI) p value
Nurse participation in hospital affairs 0.25 0.10 to 0.41 .001
Collegial nurse-physician relations −0.19 −0.35 to −0.03 .02
Barriers to protective equipment use** 0.65 0.36 to 0.93 <.001
Nursing workloads 0.03 0.01 to 0.04 <.01
Non-private practice ownership 0.37 0.10 to 0.64 <.01
*
Multivariable linear regression analysis using generalized estimating equations to account for clustering of nurses within practices.
**
Barriers to Protective Equipment Use scale is reverse scored (higher score reflects fewer barriers).
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Table 4
Organizational Factors and Hazardous Drug Spills
OR (95 % CI) P value
Nurse Manager Ability, Leadership, and Support 0.68 0.47 to 0.98 .04
Barriers to Protective Equipment Use 0.65 0.35 to 1.21 .17
Nursing Workloads 1.03 1.01 to 1.06 .01
Logistic regression using generalized estimating equations to account for clustering of nurses within practices. OR: odds ratio. 95% CI: 95% 
confidence interval.
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